Bacterial phage associated lysing enzymes for treating dermatological infections
US6248324A · kind A · utility
47Cited by
6References
12Claims
0Family size
Inventors
Key dates
| Filing date | Sep 28, 2000 |
| Grant date | Jun 19, 2001 |
| Priority date | — |
| Expiry date | Sep 28, 2020 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12Y302/01017
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention discloses a composition for dermatological infections by the use of a lytic enzyme in a carrier suitable for topical application to dermal tissues. The method for the treatment of dermatological infections comprises administering a composition comprising effective amount of a therapeutic agent, with the therapeutic agent comprising a lytic enzyme produced by infecting a bacteria with phage specific for that bacteria.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.